FamiCord AG
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VTIAF research report →
About the company
FamiCord AG engages in the collection, logistics, processing, and storage of stem cells from umbilical cord blood, umbilical cord tissue, and other postnatal tissues, serving as a full-service provider for cryopreservation. It also engages in the development of products and drugs derived from cells, tissues, and blood for medical applications. Additionally, FamiCord is active in Cell & Gene therapies and operates as a CDMO.
- CEO
- Jakub Julian Baran
- IPO
- 2014
- Employees
- 771
- HQ
- Leipzig, NV, DE
Price Chart
- Market Cap
- $111.13M
- P/E
- -10.61
- P/S
- 0.70
- P/B
- 11.97
- EV/EBITDA
- 10.83
- Div Yield
- 0.00%
- Gross Margin
- 58.14%
- Op Margin
- -3.28%
- Net Margin
- -6.74%
- ROE
- -58.37%
- ROIC
- -2.60%
- Revenue
- $88.14M · 7.25%
- Net Income
- $-6,300,638 · 48.08%
- EPS
- $-0.36 · 48.57%
- Op Income
- $-3,516,682
- FCF YoY
- -104.56%
- 52W High
- $7.00
- 52W Low
- $5.10
- 50D MA
- $6.38
- 200D MA
- $6.36
- Beta
- 0.64
- Avg Volume
- 19.412
Get TickerSpark's AI analysis on VTIAF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our VTIAF coverage
Recent articles, reports, and earnings notes.
No research on VTIAF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VTIAF report →Similar companies
Peers in the same neighborhood.